FDA Approves New Parkinson's Drug to Lessen "Off" Time | FoxFlash April 2020

Newly Approved Parkinson's Drug Aims to Lessen "Off" Time The U.S. Food and Drug Administration (FDA) recently approved Ongentys (opicapone), a new Parkinson's medication that works with levodopa to give better symptom control and less "off" time (when Parkinson's symptoms return) throughout the day. Continue Reading > Getting Started with Fox Insight: An Important Online Study April 29, 2020 at 12 p.m. ET What We Fund: $10.4 Million in New Parkinson’s Research Grants MJFF remains committed to the PD research community. We are ensuring that research moves forward through our funding programs, which include 72 new grant awards totaling nearly $10.4 million. Learn More > Share Your Experience with COVID-19 Today, we don't know much about how COVID-19 is impacting the Parkinson's community. MJFF's online clinical study, Fox Insight, is here to change that. Join Fox Insight > A Special Message from Michael J. Fox to the Parkinson's Community Along with a message from our founder, MJFF's dedicated COVID-19 hub has information and resources to support the worldwide Parkinson's community through this challenging time. Visit the Hub > Can Telehealth Work for Parkinson's? Though telehealth wasn’t in wide use for Parkinson's before the pandemic, MJFF has invested in research showing it can be useful in research and patient care. Find Out More > What We're Advocating for on Capitol Hill Amidst the Pandemic MJFF is working with congressional aides and colleague organizations in the health and research advocacy field to make sure the PD community is represented in COVID-19 support efforts. Read More > Rock Steady Boxing Offers At-Home Workout Series Rock Steady Boxing, which specializes in non-contact boxing for people with PD, recently launched a new YouTube series to provide simple, safe ways to keep the community moving at home. Stay Active >